Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Supportive care and symptom management

CN63 - Intervention pathways for low anterior resection syndrome after sphincter-saving rectal cancer surgery: A systematic scoping review.

Date

11 Sep 2022

Session

Supportive care and symptom management

Topics

Supportive Care and Symptom Management;  Survivorship

Tumour Site

Colon and Rectal Cancer

Presenters

Eva Pape

Citation

Annals of Oncology (2022) 33 (suppl_7): S827-S836. 10.1016/annonc/annonc1046

Authors

E. Pape1, J. Burch2, G.H. van Ramshorst1, Y. Van Nieuwenhove1, C. Taylor2

Author affiliations

  • 1 Gastrointestinal Surgery, UZ Gent - Universitair Ziekenhuis Gent, 9000 - Gent/BE
  • 2 Surgery, St Mark's Hospital, HA1 3UJ - Harrow/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract CN63

Background

An increased number of rectal cancer survivors are living with disordered bowel function, which is called low anterior resection syndrome. There is no gold standard in treatment so to manage their bowel function, patients search for strategies and compromises but rely mostly on trial and error. Several intervention pathways for LARS are suggested in the literature. The problem is that there is a great discrepancy between the treatment options within the pathway. This systematic scoping review aims to map the range of intervention pathways for LARS after sphincter-saving rectal cancer surgery.

Methods

A systematic search was performed through four databases (CINAHL, EMBASE, PubMed, and Web of Science) plus exploration of reference lists of included papers. Any type of paper was included if it described an intervention pathway of bowel problems after sphincter-saving rectal cancer surgery. Exclusion criteria were absence of full paper, no intervention pathway, not being written in English or Dutch and patients with a stoma. A narrative synthesis of the results of included studies is presented.

Results

Of 373 identified papers, 12 were included in this scoping review. Despite similarities in treatment options there were variations in which treatments are included, when treatments should be instigated and even which patients should be treated. Treatment pathways included different steps (ranging from 2 to six) and different interventions (ranging from 5 to 9), commonly starting with conservative treatment and dietary alterations and ending with a discussion about stoma formation. Some intervention pathways also described preoperative and/or pre-stoma reversal interventions.

Conclusions

There is no single definitive treatment pathway, and additionally, multimodal treatments are described. Nonetheless, guidance is necessary for HCPs and patients to ensure that appropriate care is provided. However, there is a lack of evidence to support many potentially useful interventions in a bowel symptom management pathway for people after rectal cancer surgery, particularly for conservative treatment. Additional work is necessary to determine how best to recognize, assess and address symptoms.

Clinical trial identification

The study was registered with Open Science Framework (10.17605/OSF.IO/JB5H8).

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.